Home » Topics » BioWorld Science

BioWorld Science
RSS

New pancreatic cancer immune therapy target identified

Dec. 15, 2021

Guangzhou Fermion Technology patents SST4 receptor agonists

Dec. 15, 2021

Oncolys BioPharma discloses new compounds against SARS-CoV-2 infection

Dec. 15, 2021

Siglec-15 expression is increased in leukemia and its targeting may be promising for therapy

Dec. 15, 2021

TYME-19 demonstrates antiviral effect against SARS-CoV-2 in human lung epithelial cells

Dec. 14, 2021

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

Dec. 14, 2021

CVL-218 shows promising potency and safety in preclinical models

Dec. 14, 2021

3SBio's Sunshine Guojian subsidiary to develop Numab's NM-28 in Greater China area

Dec. 14, 2021

Targeting CXCL16 shows therapeutic effects in model of TNBC

Dec. 14, 2021

Liver humanized NSG-PiZ mouse model developed to test HBV antiviral therapies

Dec. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...